title: The pharmacological treatment of urinary incontinence.
authors.affiliation: The Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden. Karl-Erik.Andersson@klinfarm.lu.se
authors.forename: K E
authors.initials: KE
authors.lastname: Andersson
authors.forename: R
authors.initials: R
authors.lastname: Appell
authors.forename: L D
authors.initials: LD
authors.lastname: Cardozo
authors.forename: C
authors.initials: C
authors.lastname: Chapple
authors.forename: H P
authors.initials: HP
authors.lastname: Drutz
authors.forename: A E
authors.initials: AE
authors.lastname: Finkbeiner
authors.forename: F
authors.initials: F
authors.lastname: Haab
authors.forename: R
authors.initials: R
authors.lastname: Vela Navarrete
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy*
chemical_list: D000317:Adrenergic alpha-Antagonists; D006728:Hormones; D007473:Ion Channels; D018727:Muscarinic Antagonists